Table 4.
Comparison of prevalence of microangiopathies in the study population with and without Metabolic Syndrome
| Metabolic Syndrome | Diabetic Retinopathy, n = 255 | p | Diabetic Nephropathy, n = 264 | p | Diabetic Neuropathy, n = 264 | p |
|---|---|---|---|---|---|---|
| Overall | ||||||
| Absent (n = 371) | 79 (21.3) | 0.057 | 76 (20.5) | 0.296 | 63 (17.2) | 0.353 |
| Present (n = 1043) | 176 (16.9) | 188 (18.0) | 201 (19.4) | |||
| Men | ||||||
| Absent (n = 260) | 61 (23.5) | 0.241 | 60 (23.1) | 0.029 | 46 (17.9) | 0.304 |
| Present (n = 490) | 97 (19.8) | 81 (16.5) | 103 (21.1) | |||
| Women | ||||||
| Absent (n = 111) | 18 (16.2) | 0.599 | 16 (14.4) | 0.222 | 17 (15.6) | 0.556 |
| Present (n = 553) | 79 (14.3) | 107 (19.3) | 98 (17.9) |